Figures computed from official regulatory filings — .
Ownershipinsiders 0% · institutions 0% · short 4.5% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for RVL Pharmaceuticals plc only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
RVL Pharmaceuticals plc operates as a specialty pharmaceutical company in the United States, Argentina, and Hungary. It focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas. It is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January 2022. RVL Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
11 buys6 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Harsaul Foundation | Sell | $468.2K | SEC | ||
| Harsaul Foundation |
| Sell |
| $142.8K |
| SEC |
| Altchem Ltd | Sell | $468.2K | SEC |
| Altchem Ltd | Sell | $142.8K | SEC |
| Altchem Ltd | Sell | $205.3K | SEC |
| Harsaul Foundation | Sell | $205.3K | SEC |
| Avista Healthcare Partners GP, Ltd. | Other | n/a (No price was disclosed in the filing) | SEC |
| Lask Alisa | Other | $5.9K | SEC |
| Lask Alisa | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| DeBiasi Michael J. | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| COWAN GREGORY L | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Schaub James | Other | $4.9K | SEC |
| Klein Christopher | Other | $4.7K | SEC |
| Venkataraman Sriram | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Burgstahler David Ftrack record | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Orbit Co-Invest III LLC | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Schaub James | Other | $12.1K | SEC |
| Klein Christopher | Other | $12.1K | SEC |
| Lask Alisa | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Schaub James | Buy | $232.5K | conv 53Cluster | SEC |
| Venkataraman Sriram | Buy | $12.4M | conv 59ClusterFirst in 12mo | SEC |
| MARKISON BRIAN A | Buy | $1.3M | conv 65ClusterFirst in 12mo | SEC |
| Orbit Co-Invest III LLC | Buy | $12.4M | conv 59ClusterFirst in 12mo | SEC |
| Burgstahler David Ftrack record | Buy | $12.4M | conv 68ClusterUnusual size+1 | SEC |
| deVries Tina Marie | Other | $7.6K | SEC |